SCHEMBL9254062

SCHEMBL9254062

O=Cn1ccnc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7260805 0.75 LMNA (0.34)
SCHEMBL17771238 0.73
SCHEMBL27495376 0.71
SCHEMBL28279446 0.71
SCHEMBL548609 0.71
SCHEMBL2906953 0.71
SCHEMBL27332692 0.71
SCHEMBL16296076 0.71
SCHEMBL27893063 0.67 ALDH1A1 (0.33)
SCHEMBL2397517 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101568533-A 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors ACTELION PHARMACEUTICALS LTD (CH) 2009-10-28 CN disclosed
CN-101506199-A Azetidine compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD (CH) 2009-08-12 CN disclosed
US-5384412-A 4-trihydrocarbylsiloxy-6-methyltetrahydropyran derivatives; anticarcinogenic agents THE SCRIPPS RESEARCH INSTITUTE (US) 1995-01-24 US disclosed
EP-0530225-A4 INTERMEDIATES IN THE FORMATION OF THE CALICHEAMICIN AND ESPERAMICIN OLIGOSACCHARIDES 1993-09-22 EP disclosed
EP-0530225-A1 INTERMEDIATES IN THE FORMATION OF THE CALICHEAMICIN AND ESPERAMICIN OLIGOSACCHARIDES THE SCRIPPS RESEARCH INSTITUTE (US) 1993-03-10 EP disclosed
WO-1991017158-A1 INTERMEDIATES IN THE FORMATION OF THE CALICHEAMICIN AND ESPERAMICIN OLIGOSACCHARIDES SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1991-11-14 WO disclosed